Max Financial Services Board Approves Appointment of Mr. Bharat Anand as Additional Director

The Board of Directors of Max Financial Services Limited approved the appointment of Mr. Bharat Anand as an Additional Director (Non-Executive Independent Director). This appointment is effective from March 29, 2026, for a tenure of five years, concluding on March 28, 2031. The decision was finalized during the Board meeting held on February 11, 2026. Mr. Anand is a distinguished legal professional with extensive expertise in corporate law and M&A, currently serving as a Partner at Khaitan & Co LLP.

Board Approval for New Director Appointment

Max Financial Services Limited announced a key governance development following its Board meeting conducted today, February 11, 2026. The Board has formally approved the appointment of Mr. Bharat Anand (DIN: 02806475) as an Additional Director. He will serve in a Non-Executive Independent Director capacity, subject to subsequent shareholder approval.

Term and Effective Date

The appointment has a defined term of five (5) years. The effective date for Mr. Anand’s tenure will commence on March 29, 2026, and will remain valid up to March 28, 2031. The Board meeting took place between 1645 hours (IST) and 1715 hours (IST) on the date of the announcement.

Director Profile Summary

Mr. Bharat Anand is highlighted as a highly accomplished figure in the legal sphere, bringing significant expertise in corporate law, mergers & acquisitions, private equity, and venture capital. He currently serves as an Independent Director at numerous major corporations, including Mankind Pharma Limited and JK Paper Limited. Mr. Anand holds degrees from the University of Delhi and Jesus College, Cambridge University. He is noted for his consistent high rankings in domestic and international legal publications, such as Chambers & Partners and Legal 500. Importantly, the disclosure confirms that Mr. Anand is not related to any other Director of the Company and is not debarred by any regulatory authority.

Source: BSE

Previous Article

Piramal Pharma Limited Imposition of ₹1 Crore Environmental Damage Compensation at Dahej Site

Next Article

ICICI Lombard General Insurance Intimation of Schedule for Analyst/Institutional Investor Meets in February 2026